SCHEMBL24307172

SCHEMBL24307172

c1ccc2c(c1)Oc1cc(-c3ccc4c(c3)oc3ccccc3c3ccccc3c3ccccc43)cc3c1B2c1ccccc1O3

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCRTR1 O43613 1/20 0.39
AHR P35869 2/20 0.39
MEN1 O00255 6/20 0.38
KMT2A Q03164 6/20 0.38
MAPT P10636 5/20 0.38
ALDH1A1 P00352 4/20 0.38
KDM4E B2RXH2 3/20 0.38
HPGD P15428 3/20 0.38
NPC1 O15118 5/20 0.36
RAB9A P51151 4/20 0.36
SMN1; SMN2 Q16637 4/20 0.36
MMP12 P39900 1/20 0.36
MMP13 P45452 1/20 0.36
ATM Q13315 1/20 0.36
MAOA P21397 4/20 0.35
CASP3 P42574 1/20 0.34
SENP7 Q9BQF6 1/20 0.34
SENP6 Q9GZR1 1/20 0.34
GLA P06280 1/20 0.33
CYP3A4 P08684 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24002420 0.99 HCRTR1 (0.40) HCRTR1AHRMEN1KMT2AMAPT
SCHEMBL24307160 0.93 MAPT (0.40) HCRTR1AHRMEN1KMT2AMAPT
SCHEMBL16890598 0.92 MAPT (0.41) HCRTR1AHRMEN1KMT2AMAPT
SCHEMBL21793856 0.91 HCRTR1 (0.38) HCRTR1AHRMEN1KMT2AMAPT
SCHEMBL16889355 0.91 MAPT (0.40) HCRTR1AHRMEN1KMT2AMAPT
SCHEMBL24307161 0.89 AHR (0.41) HCRTR1AHRMEN1KMT2AMAPT
SCHEMBL21793754 0.88 HCRTR1 (0.38) HCRTR1AHRMEN1KMT2AMAPT
SCHEMBL16889349 0.88 PLA2G2A (0.40) HCRTR1AHRMEN1KMT2AMAPT
SCHEMBL16889448 0.86
SCHEMBL21793857 0.84 MAPT (0.39) HCRTR1AHRMEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220119418-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2022-04-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220119418-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES BMI1, OXSR1, EED HCRTR1 148/4885AHR 1880/4885MEN1 1710/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.